Last Close
May 21  •  02:32PM ET
6.28
Dollar change
+0.11
Percentage change
1.78
%
Index
RUT
P/E
-
EPS (ttm)
-0.38
Insider Own
51.11%
Shs Outstand
21.33M
Perf Week
-1.10%
Market Cap
171.74M
Forward P/E
6.05
EPS next Y
1.04
Insider Trans
0.00%
Shs Float
13.37M
Perf Month
24.60%
Enterprise Value
169.99M
PEG
-
EPS next Q
-0.02
Inst Own
41.95%
Perf Quarter
-26.12%
Income
-9.59M
P/S
2.66
EPS this Y
113.83%
Inst Trans
18.85%
Perf Half Y
-21.01%
Sales
64.68M
P/B
5.57
EPS next Y
1496.15%
ROA
-10.86%
Perf YTD
-18.55%
Book/sh
1.13
P/C
6.31
EPS next 5Y
-
ROE
-36.61%
52W High
9.56 -34.28%
Perf Year
-7.37%
Cash/sh
1.00
P/FCF
-
EPS past 3/5Y
34.88% -
ROIC
-17.85%
52W Low
4.31 45.71%
Perf 3Y
355.07%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-5.66% 6.79%
Gross Margin
58.76%
Volatility
8.07% 6.17%
Perf 5Y
-
Dividend TTM
-
EV/Sales
2.63
EPS Y/Y TTM
3.18%
Oper. Margin
-9.80%
ATR (14)
0.38
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
1.47
Sales Y/Y TTM
15.00%
Profit Margin
-14.82%
RSI (14)
65.27
Dividend Gr. 3/5Y
- -
Current Ratio
1.72
EPS Q/Q
54.64%
SMA20
14.89%
Beta
1.07
Payout
-
Debt/Eq
0.83
Sales Q/Q
21.48%
SMA50
11.86%
Rel Volume
0.49
Prev Close
6.17
Employees
58
LT Debt/Eq
0.74
SMA200
-13.33%
Avg Volume
255.94K
Price
6.28
IPO
Nov 12, 2021
Option/Short
Yes / Yes
Trades
Volume
99,407
Change
1.78%
Date Action Analyst Rating Change Price Target Change
Aug-25-25Initiated H.C. Wainwright Buy $13
Jul-30-25Resumed B. Riley Securities Buy $12
Aug-22-24Initiated Rodman & Renshaw Buy $9
Jun-28-24Resumed ROTH MKM Buy $11
Dec-07-21Initiated B. Riley Securities Buy $14
May-19-26 04:45PM
May-14-26 08:25PM
01:01AM
May-13-26 04:01PM
May-06-26 04:01PM
08:30AM Loading…
Apr-21-26 08:30AM
Mar-26-26 08:30AM
Mar-25-26 11:01PM
04:01PM
Mar-24-26 09:16AM
Mar-18-26 08:30AM
Jan-08-26 02:00PM
Dec-10-25 08:30AM
Nov-19-25 08:18AM
Nov-17-25 08:06PM
06:30PM Loading…
Nov-12-25 06:30PM
05:15PM
04:01PM
Nov-11-25 07:31AM
Nov-10-25 05:20PM
Nov-05-25 06:35PM
08:30AM
Nov-04-25 06:35PM
Oct-24-25 08:30AM
Oct-08-25 08:30AM
Sep-22-25 09:03AM
Sep-04-25 08:06AM
Sep-03-25 08:30AM
Aug-18-25 08:30AM
Aug-13-25 07:00PM
05:15PM Loading…
Aug-12-25 05:15PM
04:01PM
Aug-11-25 09:36AM
09:10AM
Aug-07-25 08:30AM
Aug-05-25 04:01PM
Aug-04-25 10:00AM
Jul-14-25 08:30AM
Jun-24-25 08:30AM
Jun-21-25 08:35AM
Jun-20-25 08:30AM
Jun-09-25 08:30AM
May-15-25 07:01PM
04:05PM
May-14-25 05:10PM
04:01PM
May-13-25 09:41AM
May-12-25 07:10AM
May-08-25 06:15PM
May-07-25 04:01PM
May-06-25 05:20PM
May-05-25 09:57AM
Apr-30-25 05:25AM
Apr-23-25 07:00AM
Apr-18-25 05:46PM
Apr-07-25 09:17AM
Apr-01-25 04:01PM
Mar-31-25 04:05PM
Mar-27-25 08:25AM
03:02AM
Mar-26-25 07:10PM
05:15PM
04:01PM
Mar-25-25 09:04AM
08:50AM
Mar-24-25 08:30AM
Mar-19-25 04:01PM
Mar-12-25 08:30AM
Mar-05-25 04:01PM
Mar-04-25 04:01PM
Feb-20-25 02:38PM
Jan-24-25 08:57AM
Jan-23-25 08:30AM
Nov-14-24 04:10PM
Nov-12-24 05:25PM
04:01PM
Nov-05-24 11:29AM
Nov-04-24 07:18AM
07:00AM
Oct-25-24 08:30AM
Oct-17-24 04:15PM
Oct-03-24 08:30AM
Sep-09-24 08:30AM
Sep-04-24 08:15AM
Aug-13-24 04:05PM
Aug-12-24 05:10PM
04:01PM
Aug-06-24 04:01PM
Jul-17-24 04:15PM
Jul-11-24 04:05PM
May-15-24 04:15PM
04:01PM
May-14-24 03:07AM
May-13-24 08:55PM
04:01PM
May-07-24 08:30AM
May-01-24 04:01PM
Apr-29-24 09:00AM
Apr-25-24 08:30AM
Mar-28-24 04:05PM
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.
Executive ChairmanDr. Lindsay Allan Rosenwald M.D.
FounderMr. Claude Maraoui
CFO & Corporate ControllerMr. Joseph M. Benesch
COOMr. Ramsey Alloush
Chief Commercial OfficerMr. Robert Nevin
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Maraoui ClaudePresident & CEOAug 25 '25Option Exercise0.071,250,00081,2502,397,590Aug 26 09:54 PM